Healthcare Global Enterprises' Q2 FY 2025-26 Quarterly Results

Result Summary

• Healthcare Global Enterprises Ltd reported a 4.8% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 15.0%.
• Its expenses for the quarter were up by 3.5% QoQ and 17.3% YoY.
• The net profit increased 245.5% QoQ and decreased 0.1% YoY.
• The earnings per share (EPS) of Healthcare Global Enterprises Ltd stood at 1.16 during Q2 FY 2025-26.

Financial Statments for Q2 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Healthcare Global Enterprises Ltd is a company that operates within the healthcare sector. The company specializes in providing healthcare services, with a focus on oncology, which involves the treatment and management of cancer. Given its specialization, the company is likely involved in offering a range of services that include cancer diagnosis, treatment, and research. While specific details about any recent major developments or expansions in the company were not provided, Healthcare Global Enterprises Ltd is recognized as a key player in the healthcare industry, particularly in cancer care.

Revenue

In the second quarter of the fiscal year 2026 (Q2FY26), Healthcare Global Enterprises Ltd reported total income of ₹649.47 crores. This represents a quarter-over-quarter (QoQ) increase of 4.8% from ₹619.99 crores in Q1FY26. Year-over-year (YoY), the company's total income experienced a 15.0% increase from ₹564.67 crores in Q2FY25. These figures highlight a positive trajectory in revenue generation over both the quarterly and yearly periods, suggesting an increase in the company's business activities or service offerings compared to previous periods.

Profitability

The company's profitability metrics for Q2FY26 indicate a profit before tax (PBT) of ₹19.51 crores, which is a significant 73.6% increase QoQ from ₹11.24 crores in Q1FY26. However, this marks a 29.5% decrease YoY from ₹27.68 crores in Q2FY25. Notably, the tax component for Q2FY26 was a credit of ₹0.84 crores, contrasting with the tax expenses of ₹5.94 crores in Q1FY26 and ₹6.97 crores in Q2FY25. Consequently, the profit after tax (PAT) for Q2FY26 stood at ₹20.66 crores, a substantial 245.5% increase QoQ from ₹5.98 crores in Q1FY26 and relatively stable YoY with a marginal change from ₹20.68 crores in Q2FY25. Earnings per share (EPS) for the quarter was ₹1.16, up 241.2% QoQ from ₹0.34 and reflecting a YoY decrease of 9.4% from ₹1.28.

Operating Metrics

The total expenses for Healthcare Global Enterprises Ltd in Q2FY26 amounted to ₹629.96 crores, reflecting a QoQ increase of 3.5% from ₹608.75 crores in Q1FY26 and a 17.3% increase YoY from ₹536.99 crores in Q2FY25. The financial data provided does not include specific operating metrics such as key financial ratios, but the significant changes in profit before tax and tax components are notable. The unusual negative tax value in Q2FY26 is a noteworthy anomaly compared to the positive tax expenses recorded in the previous quarters.